特瑞普利单抗联合阿昔替尼一线治疗晚期肾细胞癌的成本-效果分析
陈豪, 刘世贤, 李顺平, 窦蕾, 宋泽华
Cost-utility Analysis of Toripalimab Plus Axitinib in the First-line Treatment of Advanced Renal Cell Carcinoma
CHEN Hao, LIU Shixian, LI Shunping, DOU Lei, SONG Zehua
医药导报
.
2025, (6): 965
-972
.
DOI: 10.3870/j.issn.1004-0781.2025.06.021